
|Articles|February 11, 2008
FDA's crackdown on bio-identical hormones sparks controversy
Pharmacists are up in arms over the warning FDA has issued to seven compounding pharmacies about bioidentical hormone replacement therapy.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
4
Pharmacists Are Essential Drivers of Opioid Stewardship Programs
5






























